Therapie der Manie

• Literatur

• 1 Pfennig A, Bschor T, Baghai T et al. [S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations]. Nervenarzt 2012; 83: 568-586
• 2 Tohen M, Frank E, Bowden CL et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009; 11: 453-473
• 3 Angst J. Will mania survive DSM-5 and ICD-11?. Int J Bipolar Disord 2015; 3: 24
• 4 Severus E, Bauer M. Diagnosing bipolar disorders in DSM-5. Int J Bipolar Disord 2013; 1
• 5 Angst J. Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord 2013; 1: 12
• 6 Tohen M, Zarate Jr CA, Hennen J et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 2003; 160: 2099-2107
• 7 Kukopoulos A, Minnai G, Muller-Oerlinghausen B. The influence of mania and depression on the pharmacokinetics of lithium. A longitudinal single-case study. J Affect Disord 1985; 8: 159-166
• 8 Kukopulos A, Reginaldi D. Variations of serum lithium concentrations correlated with the phases of manic-depressive psychosis. Agressologie 1978; 19: 219-222
• 9 Rittmannsberger H, Malsiner-Walli G. Mood-dependent changes of serum lithium concentration in a rapid cycling patient maintained on stable doses of lithium carbonate. Bipolar Disord 2013; 15: 333-337
• 10 Bourin MS, Severus E, Schronen JP et al. Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study. Int J Bipolar Disord 2014; 2: 14
• 11 Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004; 6: 213-223
• 12 Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011; 378: 1306-1315
• 13 Licht RW. Limits of the applicability and generalizability of drug trials in mania. Bipolar Disord 2002; 4 (Suppl. 01) 66-68
• 14 Zarate Jr CA, Tohen M. Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry 2004; 161: 169-171
• 15 Goikolea JM, Colom F, Torres I et al. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. J Affect Disord 2013; 144: 191-198
• 16 Severus E, Taylor MJ, Sauer C et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2014; 2: 15
• 17 Cipriani A, Hawton K, Stockton S et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. Br Med J 2013; 346: f3646
• 18 Lauterbach E, Felber W, Muller-Oerlinghausen B et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 2008; 118: 469-479
• 19 Grunze H, Vieta E, Goodwin GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009; 10: 85-116
• 20 Ogawa Y, Tajika A, Takeshima N et al. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. CNS Drugs 2014; 28: 989-1003
• 21 Green AI, Tohen M, Patel JK et al. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157: 982-986
• 22 Calabrese JR, Kimmel SE, Woyshville MJ et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153: 759-764
• 23 Kendall T, Morriss R, Mayo-Wilson E et al. Assessment and management of bipolar disorder: summary of updated NICE guidance. Br Med J 2014; 349: g5673